[Therapy of pyelonephritis gravidarum].
D000667:Ampicillin / Q000627:therapeutic use; D001437:Bacteriuria / Q000175:diagnosis / Q000188:drug therapy; D002701:Chloramphenicol / Q000627:therapeutic use; D004754:Enterobacter / Q000187:drug effects; D004917:Erythromycin / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D008826:Microbial Sensitivity Tests; D009582:Nitrofurantoin / Q000627:therapeutic use; D010403:Penicillin Resistance; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D013449:Sulfonamides; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D013307:Streptomycin
Die Therapie der Pyelonephritis gravidarum.